LONDON (Reuters) – Britain’s Indivior is set to face cheap competition to its opioid addiction treatment Suboxone Film after losing a patent protection case, sending its shares more than 20 percent lower on Friday. (Source: Reuters: Health)
MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
